Zydus Looks To NASH Trials In Turkey, gVascepa Launch In The US

gRevlimid, gTrokendi Drive Record US Sales

 
• By Vibha Ravi
  
Earnings growth vector
Zydus Is Nurturing New Molecules For The Future Even As Generics Pay Off For Now • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip